Cue Biopharma
37 hedge funds and large institutions have $32.4M invested in Cue Biopharma in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 5 closing their positions.
Holders
37
Holders Change
-2
Holders Change %
-5.13%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
16
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NCM
1
Nantahala Capital Management
New Canaan,
Connecticut
|
$7.72M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$2.43M |
| 3 |
PAWC
3
P.A.W. Capital
Greenwich,
Connecticut
|
$724K |
| 4 |
4
Morgan Stanley
New York
|
$725K |
| 5 |
5
BlackRock
New York
|
$8.22M |
